Cowen initiates coverage on Transition Therapeutics (NASDAQ: TTHI) with a Market Perform rating.Analyst Ritu Baral commented, "We are initiating on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE